IntellimedIntellimed

By Bill Goodwin

Intellimed Volunteer Day with Feed My Starving Children

Intellimed Volunteer Day with Feed My Starving Children

Our team had a great time taking a day off this week to volunteer with Feed My Starving Children, a national organization dedicated to providing nutritious meals to children worldwide. While we all work hard at Intellimed and it’s not always easy to find time to take a day to volunteer like this, we always find it’s well worth it for the contributions made and time together as a team.

Here’s the stats from our volunteer day:

  • 214 boxes packed
  • 46,224 meals
  • 126 kids feed for a year
healthcare reform, BCRA, Senate Healthcare bill, healthcare senate bill, trump care, ACA, affordable care act, obamacare

By Bill Goodwin

U.S. Hospital and Medical Associations’ Positions on the Better Care Reconciliation Act (BCRA), Healthcare Senate Bill

U.S. Hospital and Medical Associations’ Positions on the Better Care Reconciliation Act (BCRA), Healthcare Senate Bill

In my effort to stay current this week on the ever-moving Senate healthcare bill reform effort – the Better Care Reconciliation Act (BRCA) – I’ve been tracking the opinions coming from the major U.S. healthcare associations, notably the hospital and medical groups.

Just shortly before and after the much-anticipated analysis from the nonpartisan Congressional Budget Office (CBO) on Monday, letters to the Senate, press releases and other statements began pouring in regarding the BRCA.

CBO analysis on Monday found that:

  • The Senate bill would increase the number of people who are uninsured by 22 million in 2026 relative to the number under current law, slightly fewer than the increase in the number of uninsured estimated for the House-passed legislation.
  • By 2026, an estimated 49 million people would be uninsured, compared with 28 million who would lack insurance that year under current law.
  • CBO and the Joint Committee on Taxation (JCT) estimate that, over the 2017-2026 period, enacting this legislation would reduce direct spending by $1,022 billion and reduce revenues by $701 billion, for a net reduction of $321 billion in the deficit over that period

The full CBO analysis can be found here.

As of today, here’s a roundup of where the various groups stand. Our intent is not to take a political position in this article, but rather to provide a roundup of hospital and medical association’s stance on the BRCA at this time.

Hospital Associations’ Positions on BCRA, Senate Healthcare Bill

American Hospital Association

In a public statement issued by Rick Pollack, President and CEO of the American Hospital Association, he stated:

Unfortunately, the draft bill under discussion in the Senate moves in the opposite direction, particularly for our most vulnerable patients. The Senate proposal would likely trigger deep cuts to the Medicaid program that covers millions of Americans with chronic conditions such as cancer, along with the elderly and individuals with disabilities who need long-term services and support. Medicaid cuts of this magnitude are unsustainable and will increase costs to individuals with private insurance. We urge the Senate to go back to the drawing board and develop legislation that continues to provide coverage to all Americans who currently have it.

National Rural Health Association

Alan Morgan, CEO of the National Rural Health Association (NRHA), said, “Members of Congress seem to be working toward a solution that perhaps makes things even worse.” NRHA has acknowledged that while the goals of the ACA were laudable, the legislation has failed in part to provide for the needs of health care in rural America.

A statement issued by Erin Mahn Zumbrun, NRHA’s Government Affairs & Policy Manager further expanded on NRHA’s position of the Senate bill:

While the bill appears to have some changes from the House version, the bill maintains some of the provisions that led to NRHA’s opposition. NRHA is disappointed that the bill includes deep Medicaid cuts that change the program from an open-ended federal commitment to a capped federal payment that limits federal spending, leaving either states, patients, or providers to struggle with the loss of funds.

The Medicaid expansion is also eliminated, being phased out over a four-year period from 2020 to 2024. Tax credits to assist individuals in purchasing insurance remain but are substantially reduced, likely leading to many more individuals unable to afford health insurance. The bill also repeals billions of taxes included in the Affordable Care Act (ACA) to pay for the coverage expansion, as well as eliminating the individual and employer mandates.

Federation of American Hospitals

On the Federation of American Hospitals (FAH) blog on June 22, the association stated its position on the BCRA:

Most providers and clinicians, including FAH, are deeply concerned by the Better Care Reconciliation Act (BCRA) discussion draft released today.  The opportunity is still there for the Senate to make critical revisions to keep the promise of accessible, affordable health care coverage and ensure Medicaid remains a viable program because it is essential to our most vulnerable neighbors. FAH has been explicit about our health reform core principles: maintain coverage levels, reasonable Medicaid structural reforms, sustain affordable, high quality individual coverage, protect employer-sponsored insurance and roll back untenable cuts to hospital reimbursement.  At this time, the BCRA draft does not sufficiently meet those principles which are so important to those Americans our community hospitals serve and our employees who care for those patients every day. Now is the time for the Senate to hit reset and make key improvements to this legislation. 

America’s Essential Hospitals

A press release issued on June 22 by America’s Essential Hospitals on BRCA stated:

Senate leaders today have put ideology ahead of lives with a plan that puts health and home at risk for millions of working Americans and that would badly weaken essential services for everyone in communities across the country.

Today’s Senate bill makes few material improvements to the deeply damaging House legislation, and might be worse overall. For the hospitals that protect millions of Americans and their communities — our essential hospitals — this bill might even accelerate decisions by some to reduce services or close their doors.

This could leave many people without local sources of lifesaving services, such as trauma, burn, and neonatal intensive care.

America’s Essential Hospitals stands by two guiding principles: affordable health care coverage for all Americans and sufficient resources for essential hospitals to meet their vital community mission. The Senate plan violates both principles and will make our nation sicker, less productive, and less secure.

We oppose this plan and appeal to senators to consider the needs of all Americans and work with us and other stakeholders — in an open and transparent process — to fix what’s wrong with our health care system while preserving progress made toward coverage and stability for all.

Medical Associations’ Positions on BCRA, Senate Healthcare Bill

American Medical Association

In a letter issued by the AMA CEO James Madara to Senate Majority Leader Mitch McConnell on the BCRA on June 26, Madara wrote:

On behalf of the physician and medical student members of the American Medical Association (AMA), I am writing to express our opposition to the discussion draft of the “Better Care Reconciliation Act” released on June 22, 2017. Medicine has long operated under the precept of Primum non nocere, or “first, do no harm.” The draft legislation violates that standard on many levels. We believe that Congress should be working to increase the number of Americans with access to quality, affordable health insurance instead of pursuing policies that have the opposite effect.

The full letter can be read here.

American Congress of Obstetricians and Gynecologists, American Academy of Family Physicians, American Academy of Pediatrics, American College of Physicians, American Osteopathic Association and the American Psychiatric Association

In a joint press release on BRCA issued June 22 by the above six major medical groups stated:

The physician leaders of six organizations representing more than half a million of America’s frontline physicians are strongly opposed to the Better Care Reconciliation Act. The U.S. Senate’s proposed health reform bill contains provisions that would do great harm to patients by repealing and undermining essential coverage and key patient protections established by the Affordable Care Act and make health care unaffordable for millions of Americans.

Given the broad impact of this bill and the magnitude of the changes made, including to the Medicaid program, our organizations are deeply concerned with the hidden and hurried manner with which this bill was drafted. We are concerned that no public hearings were held and no physician or patient expertise was sought during the bill’s development.

Payer Perspectives on BRCA

A spokesperson for America’s Health Insurance Plans told The Hill in a recent article, “We are not taking a support or oppose position.”

The Blue Cross Blue Shield Association, which represents insurers covering more than 100 million Americans stated in the same article, “We are encouraged that the draft Senate legislation funds cost-sharing reductions.”

Bill Goodwin is CEO of INTELLIMED, a leading healthcare analytics company.

By Bill Goodwin

Big Data in Other Industries & Lessons for Healthcare

Big Data in Other Industries & Lessons for Healthcare

While other industries like retail and entertainment have been able to leverage big data in impressive ways, healthcare has struggled to do so. Issues unique to the healthcare system do, however, make leveraging big data for better business intelligence a challenge:

  • A fragmented system of providers
  • Dated and/or inadequate IT infrastructure
  • HIPAA and other regulatory concerns
  • Interoperability challenges
  • Lack of standardized data

Let’s look at other industries and the role of big data in them and some examples of similar activity within the healthcare industry.

The Internet of Things

A recent Forbes article predicts that the Internet of Things (IoT) – fueled by big data – is and will continue to revolutionize retail:

  • 73% of retailers rate managing big data as important or business critical to their operations.
  • 78% of retailers say it is important or business-critical to integrate e-commerce and in-store experiences, so an omnichannel experience is delivered to every customer.
  • By 2021, 70% of retailers are planning investments in the IoT to bring greater visibility into supply chain operations to alleviate out-of-stocks and optimize selections based on customer preferences as well as give a greater voice to customers and improve the customer experience.
  • By 2021, nearly 79% of retailers will be able to customize the store visit for customers as a majority of them will know when a specific customer is in the store.

Connecting the dots between the IoT and healthcare, a HIMSS article highlights three ways the IoT can improve healthcare in ways not unlike the world of retail:

  • Operational Efficiency: Anyone who works in healthcare knows that operational issues from tracking patients to managing inventory, equipment and time (to name just a few) are big challenges. Implementing solutions such as RFID and mobile scanners connected with cloud technology can help alleviate and even resolve many of these challenges. It can help hospitals and their people have the resources on hand when and where they need them and avoid overstocking. Real-time location systems (RLTS) also have dozens of different uses within healthcare, from tracking and locating patients to keeping track of expensive medical equipment.
  • Improved Patient Care: Better allocating time to patient care versus manual tasks like documentation can be assisted with mobile devices and wearable technologies with comprehensive electronic medical records stored on them. These tools can help clinicians spend less time doing needless testing, asking redundant questions and eliminating errors.
  • Leadership and Innovation: Healthcare organizations can use big data to find common patterns and anticipate what’s on the horizon. IoT technologies can help the healthcare industry improve performance and innovation.

Big Data for Better Patient Experiences

In retail, market-basket analysis, customer segmentation and centralized customer data and intelligence are the top tech initiatives retailers are prioritizing. Within healthcare, similar tech priorities will be needed to meet patients’ expectations and for healthcare organizations to stay competitive.

Here are a few interesting examples that we found where healthcare systems are leveraging big data for better patient experiences.

An article from Kaiser highlights how hospitals in Alameda County (San Francisco, CA) – fueled by a desire to avoid hospital readmission penalties – are teaming up to share patient health records and other data in real time among their emergency departments to prevent frequent ER visits. The effort is also focused on better serving patients who do visit multiple ERs by sharing data to prevent duplicate testing and other services.

Another example of improving the customer experience and providing better care is taking place at The University of Pennsylvania. Oncologists and data scientists are digging into patient data to generate a formula to predict ER visits among oncology patients. They are using big data to prevent cancer patients from needing to go to the emergency room by developing alerts that prompt physicians to intervene earlier and provide service at a clinic or at home.

On a population health level, as a diagnostic tool, big data allows doctors to build patient profiles and diagnostic maps for diseases and disorders. Diseases as common as the common cold to large-scale epidemics and pandemics can be better treated and managed.

An example of this can be seen in the Ebola outbreak in Africa in 2014, where big data was used to combat Ebola’s spread. The effort started with mobile mapping, allowing the CDC and Swedish non-profit Flowminder to both map typical population movement patterns as well as measure where cases seemed to be popping up. By tracking sources of calls to helplines, they could understand and predict outbreak locations. 

Summary

Given the pace of technological advances across all industries, it’s only a matter of time before big data transforms healthcare as it has and continues to do in other industries. Healthcare has some unique challenges to overcome. But, as you can see by the examples we’ve shared here, innovative healthcare systems are already leveraging the power of big data to improve their operations, patient care and bottom line.

Bill Goodwin is CEO of INTELLIMED, a leading healthcare analytics company.

personalize medicine

By Bill Goodwin

Personalized Medicine & Big Data: Are We Finally Moving Forward?

Personalized Medicine & Big Data: Are We Finally Moving Forward?

Did you know that the concept of personalized medicine dates to the days of Hippocrates – the father of modern medicine? Of course, Hippocrates did not have access to the amount of data today’s medical professionals have available to them.

In our modern times, the spark for personalized medicine was lit primarily by knowledge arising from the Human Genome Project at the beginning of this century. In recent years, the pace of data generation has become staggering. The Institute for Health Technology Transformation reports that by the end of 2013, U.S. healthcare organizations had generated 150 Exabytes of healthcare data.

With all this data, it seems logical that it can and should be leveraged to revolutionize medicine and impact both public and personal health. Let’s focus in on personalized health and medicine.

What is Personalized Medicine?

The Personalized Medicine Coalition defines personalized medicine as:

An evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each patient. By combining the data from those tests with an individual’s medical history, circumstances and values, healthcare providers can develop targeted treatments and prevention plans.

Connecting the Dots Between Big Data & Personalized Medicine

The discussion around big data’s role in personalized medicine has been buzzing for several years now. However, it’s promise has yet to come to fruition as healthcare entities and providers struggle to leverage big data for personalized care.

Certainly, lessons can be learned from other industries and large companies like Google, Apple and Amazon who have developed solutions for managing and analyzing big data. However, it’s important to note that these examples center on management of mostly homogenous big data.

In healthcare, we are dealing with data from multiple sources, including:

  • Clinical data: e.g. medical diagnosis, medical images, patient histories, labs
  • Omics data: genomics, transcriptomics, proteomics, epigenomic, nutriomics, etc.
  • Claims data: data from public and private claims processed across health systems and providers
  • User-generated data: fitness apps, data from smart phones, etc.

Big data in healthcare translates to processing large amounts of both structured and unstructured data about individual patients. Traditional technologies can’t do this well – this is where big data technologies come into play. Integrating this data with new technologies into “smart data” – data that can be used in a meaningful way for clinical decision making – is no easy task, but it is increasingly possible.

Technology to Move Personalized Medicine Forward

Researchers in BMC Medical Genomics note a growing gap in our abilities to generate and interpret omics and other data, noting that the bottleneck is less about the ability to generate the data and more about managing, integrating, analyzing and interpreting it.

They go on to cite the following investments for success:

  • Infrastructures with cutting-edge omics facilities and analytics tools
  • Advanced digital technologies (high computing performance and storage resources)
  • Highly-qualified multi-disciplinary teams
  • Investments in security and privacy
  • The evolution and application of cloud-computing

The Business Model for Personalized Medicine 

An ongoing risk for personalized medicine is that it will be contained to middle- to high-income individuals and countries. To make personalized medicine available to the many, technology platforms will need to evolve to become scalable, more efficient and affordable.

Additionally, healthcare organizations providing personalized medicine must be able to realize a return on their investment. To offer it, it must make economic sense and fit into their larger strategic plan and service line mix.

The Shift from ‘One Size Fits All’

The promise of personalized medicine is the shift away from ‘one size fits all’ medicine. In summary, shifts within healthcare, as outlined in a Gartner article ‘Personalized Medicine is Approaching Faster than You Think!’, will continue to move us in the right direction.

  1. Falling costs: Now it takes a few thousand dollars to sequence the human genome, compared to more than a billion USD in the ‘90s.
  2. Electronic health record adoption: Notably national EHR programs and initiatives that pull data from multiple healthcare organization, labs, etc.
  3. Government lead directive: While the direction of U.S. healthcare is a bit uncertain, most agree we will continue to move toward a value-based versus volume-based model and government will, hopefully, continue to invest in advancements in personalized medicine.
  4. Industry collaboration developments: Continued cross-collaborations between industries and public-private partnership will fuel momentum.
  5. Patient-led demand: Consumerism is really taking hold in healthcare and patients will likely drive the demand for personalized medicine, wanting more choice and involvement in their healthcare.

Bill Goodwin is CEO of INTELLIMED, a leading healthcare analytics company.

By Bill Goodwin

Improve Your Physician Liaison Programs with Insights from Leading Healthcare Organizations

Survey Reveals Program Design Insights and Benchmarking Data for Hospital Physician Liaison Programs

Access the FREE White Paper now.

Expanding service lines, growing market share, improving brand and attracting patients…

Do these goals sound familiar? And, increasingly challenging to attain? 

Strong physician relationships and physician referral programs are at the heart of achieving these goals.

Physician liaisons are on the frontline when it comes to making it all happen.

We reached out to our customers and partners – leading healthcare organizations nationwide – and surveyed them for their insights.

Findings from the survey revealed key information on physician liaison program practices for:

  • Compensation design, including information on pay mix, frequency and performance measures.
  • Deployment practices including liaisons to bed count and deployment practices by geography and service line.

These findings are in our FREE white paper, which also includes:

  • The most commonly shared challenges and concerns around designing physician liaison programs.
  • Performance measures best practices and tips.
  • The role of marketing and data tools in physician liaison program success.
  • Key questions for using data for physician liaisons on up to the C-suite.

Access the FREE White Paper now.

By Bill Goodwin

Current Physician Identified Inpatient and Outpatient Medicare Data Now Available from Intellimed

Current Physician Identified Medicare Inpatient and Outpatient Data Now Available from INTELLIMED

Quarterly updated Medicare outpatient and inpatient data with physician names is now available. Over 44 million new quarterly Medicare claims are available every quarter for immediate analysis.

PHOENIX, February 28, 2017 — Intellimed is pleased to announce the availability of current quarterly Medicare Inpatient and Outpatient data including attending and operating physicians associated with each case. The data is updated every quarter and is at most 90 days old.

“Medicare represents such a large portion of all claims activity”, said Bill Goodwin, CEO of Intellimed.  “With the addition of current Medicare data, we can give clients an excellent view into both inpatient and outpatient activity that is happening right now in their markets. And given the fact that most states do not have state or hospital association provided outpatient market data, this data gives them a great window into market behavior and competitive trends.”

Intellimed has over 170 million annual Medicare claims for inpatient and outpatient activity for each year since 2008, and each quarterly updated is approximately 44 million in new claims.

Intellimed has mapped the NPIs, the historical Medicare discharges to physician activities that can be tracked over time to see changes in practice patterns, outcomes and organizational allegiances. The mapping was completed for all patients from 2008 through 2016 and with detailed record level viewing. “This is a big step forward in helping healthcare organizations more effectively plan and favorably impact their respective markets,” commented Gene Koch, COO of Intellimed.

This dataset will be especially useful for organizations that operate in states with no or restricted access to physician data, and in states where the current provided data is rather old when they receive it. All Medicare data will continue to be severity adjusted by the MS-DRG and 3M APR-DRG groupers.

For information about pricing and availability, please contact Intellimed: 888-214-1415.

healthcare big data

By Bill Goodwin

The Outlook for Healthcare Big Data in 2017: Integrating Data for Business Decision Making

The Outlook for Healthcare Big Data in 2017: Integrating Data for Business Decision Making

Big data has held big promise for healthcare for some time now. However, healthcare leaders continue to struggle with fully integrating healthcare big data into clinical and business decision making in ways that positively impact patient care and their bottom lines.

So, what does 2017 hold for healthcare big data and using big data in hospitals? We don’t have a crystal ball, of course, but given what we’ve seen in our work in healthcare data analytics, in our conversations with our clients who work with data regularly and in keeping up on the latest predictions, here are some thoughts.

Closing Data Silos
I recently read a blog by Forrester’s Kate McCarthy where, not surprisingly, she predicts in 2017 that payers and providers will need to integrate unstructured data to gain patient and customer insight. She notes health clouds as a tool for providers to utilize.

We see the challenge of integrating huge amounts of healthcare big data from doctors’ offices, hospitals, labs, clinics and claims data regularly. Of course, the nation’s large healthcare systems have already created internal health information exchanges for their own data to provide access to one set of records across the healthcare system. Examples include Kaiser Permanente’s Health Connect and Pittsburgh Health’s Data Alliance. Integrating data across systems outside of their own and integrating clinical data with business intelligence data will be the next big step for many larger healthcare systems in 2017, while others will remain focused on connecting their internal data silos.

Data and Consumer Marketing
In 2015, the percent of insurance business served by group contracts dropped by 48 percent, an indicator that healthcare payers and providers will likely continue shifting to other models including increased growth in business-to-consumer (B2C) models. Insights from big data can be used to tailor and personalize patient experiences within the healthcare system. Healthcare will continue to implement strategies informed by data from the world of B2C marketing.

Data & Clinical Care
Obamacare outcome mandates around things like hospital readmissions have prompted healthcare systems to leverage healthcare big data to tackle the challenges that impact healthcare costs and quality the most. 2017 will see an increased use of big data for prevention, diagnosis, treatment and follow-up care. Big data will also play a major role in personalized medicine as a treatment option.

Patient-Collected Data

It is predicted that by 2020, 40 percent of employees can cut their healthcare costs by wearing a fitness tracker. As the technology of wearables evolves, integration of patient-generated and collected data will begin to play a greater role in employee benefits and insurance plans as well as informing clinical care. On the heels of fitness trackers like Fitbit, Jawbone and others, now come the next wave of devices focused on chronic diseases like diabetes and heart disease. These tools offer more promise for integrating patient-collected data with clinical data for monitoring and delivering care.

Evolving Role of the CIO
We don’t envy the role of the hospital CIO, as it’s a challenging job in today’s complex healthcare landscape. The role of healthcare CIO will continue to be one of working cross-functionally within the healthcare organization. CIOs will need to continue to challenge how things have always been done and use data in new and innovative ways in the rapidly transforming healthcare market.

Summary
As we head into a New Year, we look forward to seeing how big data will evolve healthcare. Regardless of what happens, we know big data will continue to play an increasing role in the delivery of care and in the business decisions that are made within healthcare organizations.

We’d love to hear your thoughts on how big data will impact healthcare in 2017. Please share your comments!

Bill Goodwin, MBA is CEO of INTELLIMED, a healthcare data analytics company based in Phoenix, Arizona.

Healthcare big data

By Bill Goodwin

Three Tips to Prevent Big Data From Causing Big Problems

Three Tips to Prevent Big Data From Causing Big Problems

If you are like most leaders in business, you hear the words “Big Data” being used in promotions, internal meetings, vendor presentations and more. Big data – to an increasing extent – has become synonymous with “we can help you find the answers you need and improve profits.”

And, there is some truth in this statement. According to the International Institute for Analytics, businesses that use data will see $430 billion in productivity benefits over their competition not using data. Forrester predicts that real-time streaming insights into big data will be the hallmarks of data winners going forward. Without a doubt, data can help us make better more informed decisions. However, it is possible to over-rely on big data as a panacea for answers to complex healthcare business decisions.

Countless times I have been in meetings with vendors, internal personnel and clients where healthcare big data is mentioned in some form or another as being the solution to helping (better yet telling) them what to do. The competitive pressure in all markets today forces individuals to make decisions faster and more accurately, so the appeal of fresh insights from new clinical data analysis becomes extremely appealing.

In many ways, tapping into healthcare big data analytics can help, but all of us should be extremely careful about placing too much stock in there always being clear, action-oriented and effective go-forward strategies to be found in big data. In fact, I have been in front of many prospective clients over the last few years and they mention, albeit sometimes reluctantly, that they have been burned by previous companies who offer data-driven tools designed to provide answers they had previously been unable to find. So not only has big data in hospitals been marketed as the solution, it has also started to develop a reputation as being overrated.

Big data, more accurately described, is a general, all-inclusive term for a variety of complex data collection, processing and analysis generation that traditional applications are unable to handle. There is no question the accumulation and analysis of new data can be helpful to every organization. However, take ten organizations in the same industry that have the same big data inputs and I guarantee all will come out with different conclusions on what they should do next. Seems logical, yes, but how do you ensure your organization is not one of the ones that makes a critical misstep?

While big data can certainly provide critical insights for healthcare decision makers, we must approach big data cautiously and through a measured perspective. Here are three important considerations with regard to big data to leverage immediately:

  • Be Aware of Personal and Internal Bias
    All analyses have some level of personal or organizational bias. Whether it is how the analyses are set up or how the information is interpreted, it is essential to a) know there will always be bias and b) try to factor that out in the final interpretation. In other words, while there is no way to fully eliminate bias, you can be aware of what it is and modify your interpretation accordingly. Most leaders are aware that there is bias in all analyses, yet some continue to make decisions without taking bias into consideration.
  • Understand Correlation Versus Causation
    I have seen too many leaders make detrimental decisions when they mistake correlation with causation. High positive or high negative correlation does not always mean causation, whether one is looking at two variables or a multi-variable analysis. Be sure to factor this in before any major decisions are made. Dig deeper, look at the problem or opportunity from more angles and get other viewpoints before settling in on the final decision.
  • Tap Into Your Intuition
    In this new data-driven society, we are becoming so data dependent that using intuition is becoming a thing of the past. In fact, I would argue the art of intuition has been lost in many organizations. We have all had situations where the “data” told us to turn left, but our gut told us to turn right. And, how many times did all of us turn left due to an analyses only to find out right was the better direction? Intuition is essential to any decision-making process and simply cannot be excluded. If you don’t have a good feel for the decision you need to make, rely on data more. If your intuition is telling you what decision you should make, pay more attention to it, regardless of what the analysis suggests.

Some data experts predict that we have already begun to move away from the era of big data in favor of “fast data” and “actionable data,” noting that most businesses don’t use a fraction of the data they have access to and should focus on asking the right questions to make the best use of data, big or otherwise. Certainly these data analytics changes will enable us to continue to enhance our insights and subsequent decisions.

With the continual advancement of how we access and perform big data analytics as a service, it’s hard to argue that it’s not a necessary component of healthcare decision making – but it’s not the only factor. Regardless of the direction that big data goes, coupling the knowledge gained from data with our experience and intuition – and knowing when to favor one over the other – will become increasingly important in our complex healthcare landscape.

Bill Goodwin is CEO of INTELLIMED, a leading healthcare analytics company.

Intellimed Volunteer Day with Feed My Starving Children
healthcare reform, BCRA, Senate Healthcare bill, healthcare senate bill, trump care, ACA, affordable care act, obamacare
U.S. Hospital and Medical Associations’ Positions on the Better Care Reconciliation Act (BCRA), Healthcare Senate Bill
Big Data in Other Industries & Lessons for Healthcare
personalize medicine
Personalized Medicine & Big Data: Are We Finally Moving Forward?
Improve Your Physician Liaison Programs with Insights from Leading Healthcare Organizations
healthcare big data
The Outlook for Healthcare Big Data in 2017: Integrating Data for Business Decision Making
Healthcare big data
Three Tips to Prevent Big Data From Causing Big Problems